Table 4.
Reviewed histological diagnosis | Anatomical Site [No. (%)] | Reviewed cases with available clinical data | Clinical data unrecorded | Sub-totals | Total reviewed ML | |
---|---|---|---|---|---|---|
Nodal | Extranodal | [No. (%)] | [No. (%)] | [No. (%)] | [No. (%)] | |
DLBCL | 35 (64.8) | 7 (25.0) | 42 | 15 | 57 (50.9) | |
BL | 2 (3.7) | 15 (53.6) | 17 | 6 | 23 (20.5) | |
Other BCL* | 17 (31.5) | 6 (21.4) | 23 | 9 | 32 (28.6) | |
Total BCL | 54 (83.1) | 28 (80.0) | 82 | 30 | 112 (83.6) | 112 (83.6) |
TCL | 11 (16.9) | 7 (20.0) | 18 | 4 | 22 (13.7) | |
TOTAL NHL | 65 (65.0) | 35 (35.0) | 100 | 34 | 134 (84.8) | |
HL | 10 (66.7) | 5 (33.3) | 15 | 9 | 24 (15.2) | |
TOTAL REVIEWED ML [No. (%)] | 75 (65.2) | 40 (34.8) | 115 (72.8) | 43 (27.2) | 158 (100.0) |
*BCL = B-cell lymphomas